CSRXP: BIG PHARMA DOUBLES DOWN ON EGREGIOUS PRICE HIKES OUTPACING INFLATION
Dec 14, 2023
Administration Announces Drug Makers Increased Prices Faster Than Rate of… Read More
© 2025 CSRXP- All Rights Reserved
Press & Statements
FACT SHEET: BIG PHARMA BRINGS INSULIN PRICE-GOUGING PLAYBOOK TO BLOCKBUSTER WEIGHT LOSS DRUGS
Dec 13, 2023
Big Pharma Eyeing Egregious Price Tags, Aggressive Marketing to Push GLP-1s… Read More
CSRXP APPLAUDS FTC CRACKDOWN ON BIG PHARMA’S FLAGRANT ABUSE OF THE PATENT SYSTEM
Nov 7, 2023
Commission Targets More Than 100 Patents on Brand Name Products Listed in the… Read More
FACT SHEET: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS, TAXPAYERS AND THE U.S. HEALTH CARE SYSTEM BILLIONS OF DOLLARS
Sep 21, 2023
Big Pharma’s Anti-Competitive Tactics Are The Root Cause of Out-of-Control… Read More
CSRXP: BIG PHARMA MAKES EGREGIOUS VACCINE PRICES HIKES OFFICIAL
Sep 14, 2023
Pfizer and Moderna Raise Prices on Vaccines After Years of Taxpayer… Read More
CSRxP: Weight Loss Drugs the Latest Target for Big Pharma’s Price-Gouging of American Patients
Aug 24, 2023
Analysis Finds Brand Name Drug Makers Setting U.S. Prices for Obesity… Read More
CSRxP Poll: Voters Overwhelmingly Reject Big Pharma’s Bogus Blame Game, Support Market-Based Solutions to Lower Rx Prices by Holding Big Pharma Accountable
Aug 16, 2023
Americans from Across the Political Spectrum Want Congress to Pass Bipartisan… Read More
CSRXP: ANALYSIS FINDS 200 PERCENT INCREASE IN SECONDARY PATENT FILINGS AS BIG PHARMA EXPLOITS LOOPHOLES TO BLOCK COMPETITION
Aug 9, 2023
Over 15 Year Period, Brand Name Drug Companies Increasingly Filed for… Read More
CSRXP: BIG PHARMA INCREASES PRICES ON MORE THAN 100 BRAND NAME DRUGS IN LATEST PRICE HIKING BINGE
Jul 18, 2023
Brand Name Drug Companies Barrel Ahead with Business-As-Usual Approach to… Read More
CSRXP: PROPOSAL TO LOOSEN PATENT RULES WOULD FURTHER EMPOWER BIG PHARMA TO BLOCK COMPETITION
Jun 23, 2023
Lawmakers Should Focus on Bipartisan Solutions to Hold Big Pharma Accountable,… Read More
CSRXP COMMENDS HELP COMMITTEE FOR ADVANCING BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
May 11, 2023
Senate Panel Passes Bills to Increase Competition and Increase List Price… Read More
CSRXP: SENATORS HAVE OPPORTUNITY TO PASS BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
May 11, 2023
U.S. Senate HELP Committee Should Advance Legislation to Boost Competition and… Read More